Cargando…
Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform
BACKGROUND: Quality of residential care for people with severe dementia is in urgent need of improvement. One reason for this may be the assumption that people with severe dementia are unaware of what is happening to them. However, there is converging evidence to suggest that global assumptions of u...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908603/ https://www.ncbi.nlm.nih.gov/pubmed/20579370 http://dx.doi.org/10.1186/1745-6215-11-73 |
_version_ | 1782184201882173440 |
---|---|
author | Clare, Linda Woods, Robert T Whitaker, Rhiannon Wilson, Barbara A Downs, Murna |
author_facet | Clare, Linda Woods, Robert T Whitaker, Rhiannon Wilson, Barbara A Downs, Murna |
author_sort | Clare, Linda |
collection | PubMed |
description | BACKGROUND: Quality of residential care for people with severe dementia is in urgent need of improvement. One reason for this may be the assumption that people with severe dementia are unaware of what is happening to them. However, there is converging evidence to suggest that global assumptions of unawareness are inappropriate. This trial platform study aims to assist care staff in perceiving and responding to subtle signs of awareness and thus enhance their practice. METHODS/DESIGN: In Stage One, a measure of awareness in severe dementia will be developed. Two focus groups and an expert panel will contribute to item and scale development. In Stage Two observational data will be used to further develop the measure. Working in four care homes, we will recruit 40 individuals with severe dementia who have no, or very limited, verbal communication. Data on inter-rater reliability and frequency of all items and exploratory factor analysis will be used to identify items to be retained. Test-retest and inter-rater reliability for the new measure will be calculated. Correlations with scores for well-being and behaviour and with proxy ratings of quality of life will provide an indication of concurrent validity. In Stage Three the new measure will be used in a single blind cluster randomised trial. Eight care homes will participate, with 10 residents recruited in each giving a total sample of 80 people with severe dementia. Homes will be randomised to intervention or usual care conditions. In the intervention condition, staff will receive training in using the new measure and will undertake observations of designated residents. For residents with dementia, outcomes will be assessed in terms of change from baseline in scores for behaviour, well-being and quality of life. For care staff, outcomes will be assessed in terms of change from baseline in scores for attitudes, care practice, and well-being. DISCUSSION: The results will inform the design of a larger-scale trial intended to provide definitive evidence about the benefits of increasing the sensitivity of care staff to signs of awareness in residents with severe dementia. TRIAL REGISTRATION: ISRCTN59507580 http://www.controlled-trials.com. |
format | Text |
id | pubmed-2908603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29086032010-07-23 Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform Clare, Linda Woods, Robert T Whitaker, Rhiannon Wilson, Barbara A Downs, Murna Trials Study Protocol BACKGROUND: Quality of residential care for people with severe dementia is in urgent need of improvement. One reason for this may be the assumption that people with severe dementia are unaware of what is happening to them. However, there is converging evidence to suggest that global assumptions of unawareness are inappropriate. This trial platform study aims to assist care staff in perceiving and responding to subtle signs of awareness and thus enhance their practice. METHODS/DESIGN: In Stage One, a measure of awareness in severe dementia will be developed. Two focus groups and an expert panel will contribute to item and scale development. In Stage Two observational data will be used to further develop the measure. Working in four care homes, we will recruit 40 individuals with severe dementia who have no, or very limited, verbal communication. Data on inter-rater reliability and frequency of all items and exploratory factor analysis will be used to identify items to be retained. Test-retest and inter-rater reliability for the new measure will be calculated. Correlations with scores for well-being and behaviour and with proxy ratings of quality of life will provide an indication of concurrent validity. In Stage Three the new measure will be used in a single blind cluster randomised trial. Eight care homes will participate, with 10 residents recruited in each giving a total sample of 80 people with severe dementia. Homes will be randomised to intervention or usual care conditions. In the intervention condition, staff will receive training in using the new measure and will undertake observations of designated residents. For residents with dementia, outcomes will be assessed in terms of change from baseline in scores for behaviour, well-being and quality of life. For care staff, outcomes will be assessed in terms of change from baseline in scores for attitudes, care practice, and well-being. DISCUSSION: The results will inform the design of a larger-scale trial intended to provide definitive evidence about the benefits of increasing the sensitivity of care staff to signs of awareness in residents with severe dementia. TRIAL REGISTRATION: ISRCTN59507580 http://www.controlled-trials.com. BioMed Central 2010-06-25 /pmc/articles/PMC2908603/ /pubmed/20579370 http://dx.doi.org/10.1186/1745-6215-11-73 Text en Copyright ©2010 Clare et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Clare, Linda Woods, Robert T Whitaker, Rhiannon Wilson, Barbara A Downs, Murna Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title | Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title_full | Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title_fullStr | Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title_full_unstemmed | Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title_short | Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
title_sort | development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908603/ https://www.ncbi.nlm.nih.gov/pubmed/20579370 http://dx.doi.org/10.1186/1745-6215-11-73 |
work_keys_str_mv | AT clarelinda developmentofanawarenessbasedinterventiontoenhancequalityoflifeinseveredementiatrialplatform AT woodsrobertt developmentofanawarenessbasedinterventiontoenhancequalityoflifeinseveredementiatrialplatform AT whitakerrhiannon developmentofanawarenessbasedinterventiontoenhancequalityoflifeinseveredementiatrialplatform AT wilsonbarbaraa developmentofanawarenessbasedinterventiontoenhancequalityoflifeinseveredementiatrialplatform AT downsmurna developmentofanawarenessbasedinterventiontoenhancequalityoflifeinseveredementiatrialplatform |